Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal
about
A ventral tegmental CRF-glutamate-dopamine interaction in addiction.Adolescent caffeine consumption increases adulthood anxiety-related behavior and modifies neuroendocrine signaling.Nicotine withdrawal increases stress-associated genes in the nucleus accumbens of female rats in a hormone-dependent manner.Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke.Corticotropin Releasing Factor Binding Protein and CRF2 Receptors in the Ventral Tegmental Area: Modulation of Ethanol Binge Drinking in C57BL/6J MiceThe hypothalamic-pituitary-adrenal axis in the neuroendocrine regulation of food intake and obesity: the role of corticotropin releasing hormone.The therapeutic potential of nicotine and nicotinic agonists for weight control.Stress effects in the hippocampus: synaptic plasticity and memory.Corticotropin-releasing factor and adrenocorticotrophic hormone as potential central mediators of OB effects.The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences.Neuronal activation and corticotropin-releasing hormone expression in the brain of obese (fa/fa) and lean (fa/?) Zucker rats in response to refeeding.Distribution and regional stressor-induced regulation of corticotrophin-releasing factor binding protein in rainbow trout (Oncorhynchus mykiss).Hypothalamic CRF1 receptor mechanisms are not sufficient to account for binge-like palatable food consumption in female rats.Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2.Oestradiol modulates the effects of leptin on energy homeostasis by corticotrophin-releasing factor type 2 receptor.Corticotropin-releasing hormone-binding protein in brain and pituitary of food-deprived obese (fa/fa) Zucker rats.
P2860
Q33643410-80316812-E040-4998-BC3C-9029088E6B8CQ34514006-D4D31880-14B6-4FC2-820F-7EF03E720E06Q35608392-CF8614F8-4088-4D43-BF80-D6D4DAE9566FQ35895419-C761150A-8204-40CF-B1FA-C697066D066FQ36021677-6DAED877-5F88-4F5F-92D8-82F234B01159Q36025688-680429CB-1093-401E-832E-D84643C1EE9BQ36181346-0B512DEF-B4B7-42EC-9937-68D26C27A549Q36497427-051E6965-AA56-4027-B173-B73E00850C91Q38345036-C74D101E-21BA-482C-92A3-02460A39D718Q40828348-B5396A39-63A9-4146-ABAA-37AAB5C7461BQ43936625-1131643F-638A-4589-B544-7C2D4D671CAEQ46798946-86010896-D4E3-4F81-9ED9-FD31D7A8791CQ47661338-DFBAF0D8-2AC2-4271-A487-9B312AA2EBE7Q48106878-24E5A256-A0FA-4F98-AE0D-9EA11D32A21AQ48610403-98E6A910-EA29-441E-9544-4467E4FA1103Q51559296-36C74344-DA37-4E8A-AEE9-702E0B5C7A93
P2860
Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Corticotropin-releasing factor ...... ats during nicotine withdrawal
@en
Corticotropin-releasing factor ...... ts during nicotine withdrawal.
@nl
type
label
Corticotropin-releasing factor ...... ats during nicotine withdrawal
@en
Corticotropin-releasing factor ...... ts during nicotine withdrawal.
@nl
prefLabel
Corticotropin-releasing factor ...... ats during nicotine withdrawal
@en
Corticotropin-releasing factor ...... ts during nicotine withdrawal.
@nl
P2093
P2860
P356
P1476
Corticotropin-releasing factor ...... ats during nicotine withdrawal
@en
P2093
E B De Souza
J Lapsansky
P E Sawchenko
P2860
P304
15475-15480
P356
10.1073/PNAS.93.26.15475
P407
P577
1996-12-01T00:00:00Z